MARC Record from Library of Congress

LEADER: 01585nam a22003378a 4500
001 2008033272
003 DLC
005 20080730154240.0
008 080728s2009 nju b 001 0 eng
010 $a 2008033272
020 $a9780470393185 (cloth)
035 $a(DNLM)101479936
040 $aDNLM/DLC$cDLC
042 $apcc
043 $an-us---
050 00 $aRM301.25$bL36 2009
060 10 $aQV 736$bL217d 2009
082 00 $a615/.19$222
100 1 $aLaMattina, John L.
245 10 $aDrug truths :$bdispelling the myths about pharma R & D /$cJohn L. LaMattina.
260 $aHoboken, N.J. :$bJohn Wiley & Sons,$cc2009.
263 $a0811
300 $ap. ;$ccm.
504 $aIncludes bibliographical references and index.
505 0 $aCholesterol drugs are unnecessary -- Industry is more interested in 'me-too' drugs than innovation -- It takes industry too long to discover new drugs -- Drugs are discovered by academia -- New medicines add costs but little benefit -- Big pharma has failed and should learn from biotech success -- The industry invents diseases -- New drugs are less safe than traditional medicines -- Industry spends more on advertising than R&D -- Industry does not care about diseases of the developing world -- Big pharma's day has passed -- Final reflections.
650 0 $aDrug development$zUnited States.
650 0 $aPharmaceutical industry$zUnited States.
650 0 $aDrugs$xResearch$zUnited States.
650 12 $aDrug Industry$xeconomics$zUnited States.
650 22 $aDrug Design$zUnited States.
650 22 $aResearch Design$zUnited States.